Advertisement

Dysregulated expression of ACTN4 contributes to endothelial cell injury via the activation of the p38-MAPK/p53 apoptosis pathway in preeclampsia

  • Jianlin Zhao
  • Wei Peng
  • Yuxin Ran
  • Huisheng Ge
  • Chen Zhang
  • Hong Zou
  • Yubin Ding
  • Hongbo QiEmail author
Original Article

Abstract

Preeclampsia (PE) is a hypertensive disease associated with increased endothelial cell dysfunction caused by systemic oxidative stress. Alpha-actinin-4 (ACTN4) is a member of the α-actinin family of actin crosslinking proteins that are upregulated in several types of cancer. However, its role in PE remains unclear. In this study, we found that ACTN4 was localized in placenta vascular endothelial cells (ECs), and its expression was downregulated in primary human umbilical vein endothelial cells (HUVECs) from severe preeclamptic patients compared to that in HUVECs from normotensive pregnant women. ACTN4 expression was also decreased in normotensive HUVECs treated with H2O2. Downregulation of ACTN4 by siRNA or H2O2 treatment promoted normotensive HUVEC apoptosis and increased p38-MAPK phosphorylation along with elevated levels of p53 phosphorylation, caspase cascade proteins, and bax and repressed expression of bcl-2. Conversely, upregulation of ACTN4 in PE HUVECs significantly inhibited apoptosis and decreased p38-MAPK phosphorylation compared to that of the PE HUVEC controls. In addition, overexpression of ACTN4 in normotensive HUVECs attenuated H2O2 treatment-induced apoptosis with decreased p53 phosphorylation, caspase cascade, and bax expression levels and increased expression of bcl-2 compared to that of only H2O2 treatment. Moreover, the suppression of ACTN4 induced apoptosis, which could be blocked by the p38-MAPK inhibitor SB202190. Collectively, these results demonstrate that dysregulated ACTN4 expression may be associated with PE due to its effects on endothelial cell apoptosis via the p38-MAPK/p53 apoptosis pathway.

Keywords

Preeclampsia Endothelial cell dysfunction Oxidative stress Apoptosis P38-MAPK/p53 pathway 

Notes

Acknowledgements

We would like to acknowledge support from the “111 program” of the Ministry of Education P.R.C. and the State Administration of Foreign Experts Affairs P.R.C.

Funding information

This study was funded by the National Key Research and Development Program on the research on birth defect prevention and control of reproductive health special emphasis (No. 2016YFC1000407), the National Natural Science Foundation of China (Nos. 81520108013, 81471472, 81771613, 81501286, 81601304, 81701479, 81701480, 81801482), and the Key Program of International Cooperation of the NSFC (No. 81520108013).

Compliance with ethical standards

Conflict of interest

The authors declare that there are no conflicts of interest.

Supplementary material

13105_2019_700_MOESM1_ESM.docx (416 kb)
ESM 1 (DOCX 415 kb)

References

  1. 1.
    Brennan LJ, Morton JS, Davidge ST (2014) Vascular dysfunction in preeclampsia. Microcirculation (New York, NY: 1994) 21:4–14CrossRefGoogle Scholar
  2. 2.
    ElKeeb AM, Collier ME, Maraveyas A, Ettelaie C (2015) Accumulation of tissue factor in endothelial cells induces cell apoptosis, mediated through p38 and p53 activation. Thromb Haemost 114:364–378CrossRefGoogle Scholar
  3. 3.
    Gao Q, Zhu X, Chen J, Mao C, Zhang L, Xu Z (2016) Upregulation of P53 promoted G1 arrest and apoptosis in human umbilical cord vein endothelial cells from preeclampsia. J Hypertens 34:1380–1388CrossRefGoogle Scholar
  4. 4.
    Giannotti G, Landmesser U (2007) Endothelial dysfunction as an early sign of atherosclerosis. Herz Kardiovaskuläre Erkrankungen 32:568–572Google Scholar
  5. 5.
    Goveia J, Stapor P, Carmeliet P (2014) Principles of targeting endothelial cell metabolism to treat angiogenesis and endothelial cell dysfunction in disease. EMBO Molecular Medicine 6:1105–1120CrossRefGoogle Scholar
  6. 6.
    Hayashida Y, Honda K, Idogawa M, Ino Y, Ono M, Tsuchida A, Aoki T, Hirohashi S, Yamada T (2005) E-cadherin regulates the association between beta-catenin and actinin-4. Cancer Res 65:8836–8845CrossRefGoogle Scholar
  7. 7.
    Hiroi Y, Guo Z, Li Y, Beggs AH, Liao JK (2008) Dynamic regulation of endothelial NOS mediated by competitive interaction with alpha-actinin-4 and calmodulin. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 22:1450–1457CrossRefGoogle Scholar
  8. 8.
    Honda K (2015) The biological role of actinin-4 (ACTN4) in malignant phenotypes of cancer. Cell & Bioscience 5:41CrossRefGoogle Scholar
  9. 9.
    Hsu KS, Kao HY (2013) Alpha-actinin 4 and tumorigenesis of breast cancer. Vitamins & Hormones-Advances in Research & Applications 93:323–351Google Scholar
  10. 10.
    Hypertension in pregnancy (2013) Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol 122:1122–1131CrossRefGoogle Scholar
  11. 11.
    Jaffe EA, Nachman RL, Becker CG, Minick CR (1973) Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52:2745–2756CrossRefGoogle Scholar
  12. 12.
    Kim S, Lee KS, Choi S, Kim J, Lee DK, Park M, Park W, Kim TH, Hwang JY, Won MH, Lee H, Ryoo S, Ha KS, Kwon YG, Kim YM (2018) NF-kappaB-responsive miRNA-31-5p elicits endothelial dysfunction associated with preeclampsia via down-regulation of endothelial nitric-oxide synthase. J Biol Chem 293:18989–19000CrossRefGoogle Scholar
  13. 13.
    Koizumi T, Nakatsuji H, Fukawa T, Avirmed S, Fukumori T, Takahashi M, Kanayama H (2010) The role of actinin-4 in bladder cancer invasion. Urology 75:357–364CrossRefGoogle Scholar
  14. 14.
    Li FH, Han N, Wang Y, Xu Q (2018) Gadd45a knockdown alleviates oxidative stress through suppressing the p38 MAPK signaling pathway in the pathogenesis of preeclampsia. Placenta 65:20–28CrossRefGoogle Scholar
  15. 15.
    Liu H, Pedram A, Kim JK (2011) Oestrogen prevents cardiomyocyte apoptosis by suppressing p38alpha-mediated activation of p53 and by down-regulating p53 inhibition on p38beta. Cardiovasc Res 89:119–128CrossRefGoogle Scholar
  16. 16.
    Liu QY, Lei JX, LeBlanc J, Sodja C, Ly D, Charlebois C, Walker PR, Yamada T, Hirohashi S, Sikorska M (2004) Regulation of DNaseY activity by actinin-α4 during apoptosis. Cell Death Differ 11:645–654CrossRefGoogle Scholar
  17. 17.
    Lomert E, Turoverova L, Kriger D et al (2018) Co-expression of RelA/p65 and ACTN4 induces apoptosis in non-small lung carcinoma cells. Cell Cycle 17:616–626Google Scholar
  18. 18.
    Luo X, Yao ZW, Qi HB, Liu DD, Chen GQ, Huang S, Li QS (2011) Gadd45alpha as an upstream signaling molecule of p38 MAPK triggers oxidative stress-induced sFlt-1 and sEng upregulation in preeclampsia. Cell Tissue Res 344:551–565CrossRefGoogle Scholar
  19. 19.
    Marconcini L, Marchio S, Morbidelli L, Cartocci E, Albini A, Ziche M, Bussolino F, Oliviero S (1999) c-Fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro. Proc Natl Acad Sci U S A 96:9671–9676CrossRefGoogle Scholar
  20. 20.
    Matsuzawa Y, Lerman A (2014) Endothelial dysfunction and coronary artery disease: assessment, prognosis, and treatment. Coron Artery Dis 25:713–724CrossRefGoogle Scholar
  21. 21.
    Rao H, Bai Y, Li Q, Zhuang B, Yuan Y, Liu Y, Peng W, Baker PN, Tong C, Luo X, Qi H (2018) SATB1 down-regulation induced by oxidative stress participates in trophoblast invasion by regulating beta-catenin. Biol Reprod 98:810–820CrossRefGoogle Scholar
  22. 22.
    Redman CW, Sargent IL (2005) Latest advances in understanding preeclampsia. Science (New York, NY) 308:1592–1594CrossRefGoogle Scholar
  23. 23.
    Ribeiro JEA, Pinotsis N, Ghisleni A et al (2014) The structure and regulation of human muscle alpha-actinin. Cell 159:1447–1460CrossRefGoogle Scholar
  24. 24.
    Saito S, Nakashima A (2014) A review of the mechanism for poor placentation in early-onset preeclampsia: the role of autophagy in trophoblast invasion and vascular remodeling. J Reprod Immunol 101-102:80–88CrossRefGoogle Scholar
  25. 25.
    Sanchez-Aranguren LC, Prada CE, Riano-Medina CE, Lopez M (2014) Endothelial dysfunction and preeclampsia: role of oxidative stress. Front Physiol 5:372CrossRefGoogle Scholar
  26. 26.
    Shao H, Wu C, Wells A (2010) Phosphorylation of alpha-actinin 4 upon epidermal growth factor exposure regulates its interaction with actin. J Biol Chem 285:2591–2600CrossRefGoogle Scholar
  27. 27.
    Sjoblom B, Salmazo A, Djinovic-Carugo K (2008) Alpha-actinin structure and regulation. Cellular and Molecular Life Sciences: CMLS 65:2688–2701CrossRefGoogle Scholar
  28. 28.
    Turner NA, Moake JL (2015) Factor VIII is synthesized in human endothelial cells, packaged in Weibel-Palade bodies and secreted bound to ULVWF strings. PLoS One 10:e0140740CrossRefGoogle Scholar
  29. 29.
    Walsh SW (1998) Maternal-placental interactions of oxidative stress and antioxidants in preeclampsia. Semin Reprod Endocrinol 16:93–104CrossRefGoogle Scholar
  30. 30.
    Wang W, Deng Z, Feng Y, Liao F, Zhou F, Feng S, Wang X (2017) PM induced apoptosis in endothelial cell through the activation of the p53-bax-caspase pathway. Chemosphere 177:135–143CrossRefGoogle Scholar
  31. 31.
    Watanabe K, Mori T, Iwasaki A, Kimura C, Matsushita H, Shinohara K, Wakatsuki A (2013) Increased oxygen free radical production during pregnancy may impair vascular reactivity in preeclamptic women. Hypertens Res 36:356–360CrossRefGoogle Scholar
  32. 32.
    Won KJ, Lee KP, Kim DK, Jung SH, Lee CK, Lee DH, Yu SY, Park SH, Lee HM, Kim B (2013) Monoclonal antibody against alpha-actinin 4 from human umbilical vein endothelial cells inhibits endothelium-dependent vasorelaxation. J Vasc Res 50:210–220CrossRefGoogle Scholar
  33. 33.
    Yuan Y, Shan N, Tan B, Deng Q, Liu Y, Wang H, Luo X, He C, Luo X, Zhang H, Baker PN, Olson DM, Qi H (2018) SRC-3 plays a critical role in human umbilical vein endothelial cells by regulating the PI3K/Akt/mTOR pathway in preeclampsia. Reprod Sci 25:748–758CrossRefGoogle Scholar

Copyright information

© University of Navarra 2019

Authors and Affiliations

  • Jianlin Zhao
    • 1
    • 2
    • 3
  • Wei Peng
    • 1
    • 2
    • 3
  • Yuxin Ran
    • 1
    • 2
    • 3
  • Huisheng Ge
    • 1
    • 2
    • 3
  • Chen Zhang
    • 1
    • 2
    • 3
  • Hong Zou
    • 4
  • Yubin Ding
    • 3
    • 5
  • Hongbo Qi
    • 1
    • 2
    • 3
    Email author
  1. 1.Department of ObstetricsThe First Affiliated Hospital of Chongqing Medical UniversityChongqingChina
  2. 2.State Key Laboratory of Maternal and Fetal Medicine of Chongqing MunicipalityChongqing Medical UniversityChongqingChina
  3. 3.International Collaborative Laboratory of Reproduction and Development of Chinese Ministry of EducationChongqing Medical UniversityChongqingChina
  4. 4.Department of ObstetricsUniversity-Town Hospital of Chongqing Medical UniversityChongqingChina
  5. 5.Laboratory of Reproductive Biology, School of Public Health and ManagementChongqing Medical UniversityChongqingChina

Personalised recommendations